In neurodegenerative disorders, such as Parkinson's and Alzheimer's diseases, monoamine oxidase type B (MAO-B) is believed to play a significant role in generating reactive oxygen species during the oxidation of amine substrates. This evidence concerns the gene MAOB and early-onset autosomal dominant Alzheimer disease.